首页 | 本学科首页   官方微博 | 高级检索  
     

优化基本药物遴选模型和方法的建议
引用本文:邱鸿钟,王晓曼,梁瑞琼,金兵. 优化基本药物遴选模型和方法的建议[J]. 中国药房, 2014, 0(24): 2209-2211
作者姓名:邱鸿钟  王晓曼  梁瑞琼  金兵
作者单位:广州中医药大学经济与管理学院,广州510006
基金项目:广东省医学科研基金指令性课题项目(No.C2013019)
摘    要:目的:为完善我国基本药物遴选方法提供建议。方法:采用文献研究、数学模型等研究方法梳理并评价世界卫生组织、中国及部分国家遴选基本药物的模型和方法,指出当前我国基本药物遴选程序、模型和方法上存在的问题,并提出建议。结果:当前基本药物遴选主要有专家决策法、循证医学评价法、药物经济学评价法等。我国基本药物目录遴选主要存在遴选方法单一、指标不明确等问题。结论:建议重新构建一个五维的评价指标体系,并按证据强度采用五级评分,引入模糊综合评价模型优化基本药物的遴选。

关 键 词:基本药物  遴选模型  遴选方法  模糊综合评价法

Proposals for Optimization of the Models and Methods of Essential Medicine Selection
QIU Hong-zhong,WANG Xiao-man,LIANG Rui-qiong,JIN Bing. Proposals for Optimization of the Models and Methods of Essential Medicine Selection[J]. China Pharmacy, 2014, 0(24): 2209-2211
Authors:QIU Hong-zhong  WANG Xiao-man  LIANG Rui-qiong  JIN Bing
Affiliation:(College of Economics and Management, Guang- zhou University of TCM, Guangzhou 510006, China)
Abstract:OBJECTIVE: To provide recommendations for improving the selection methods of essential medicine in China. METHODS: The literature research methods and mathematical models were adopted. The selection models and methods of essential medicine of WHO, China and some other countries was evaluated and sorted; the problems were pointed out about the program, models and methods of essential medicine selection. RESULTS: The commonly used methods of selection including expert deci- sion-making, evidence-based evaluation method, pharmacoeconomic evalution method, etc. Essential medicine selection in China mainly exist some problems, such as selection methods is single, indicators are not unclear, etc. CONCLUSIONS: It is recom- mended to reconstruct a five-dimensional evaluation system, to adopt the five grades according to the strength of evidence, and to optimize the selection of essential medicines by introducing the fuzzy comprehensive evaluation model.
Keywords:Essential medicine  Selection model  Selection method  Fuzzy comprehensive evaluation method
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号